Jacob West, national lead for the New Models of Care Programme, said NHS England was looking at ways to help ‘pull and push’ local healthcare systems to adopt new models of working.
Speaking at a Westminster Health Forum seminar on Monday, Next steps for delivering the New Models of Care and vanguard sites, he said NHS England had an ‘ambitious’ mandate to ensure 50% of the population was covered by new care models by 2020/21.
This year is the second of the three-year vanguard programme, which has seen new models of care – including multispecialty community providers (MCPs) and primary and acute care systems (PACS) – rolled out across 50 sites in England.
Mr West said that next year - the programme's third and final year - will be about ‘mainstreaming’ the models of care trialled in these areas, with many other areas ‘adopting and adapting’ the new ways of working.
New models of care
Some of the next steps to achieve the 50% coverage target include publishing common frameworks for MCPs, PACS and care homes and sharing learning from acute care collaboration (ACC) vanguards to encourage further uptake, he added.
Multi-year MCP and PACS contracts will be developed and tested, along with new payment approaches and shared IT resources.
He said: ‘The mandate from NHS England said it wanted to see 50% of the country covered by new care models of one type or another by the end of the Five Year Forward View period. That’s a hugely ambitious trajectory.
‘I think we've learned from change programmes in the past that you probably can't just put out a document and hope other people read and implement it. This is about a multifaceted and quite sophisticated approach to supporting and encouraging local health and care systems who want to work differently.
‘Some of it is pull, that’s things like funding and so on – and there will be further funding in 2017/18 for new sites who want to adopt these kinds of models – but there is also some push – how do we make it more attractive to work in these different ways and less attractive progressively to work in the prevailing clinical models? That is the challenge we need to answer.’